NASDAQ : HSIC
Henry Schein, Inc. — Key statistics
Healthcare · Medical Distribution · United States
Last price 86.44 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 9.63B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 9.65B |
| Enterprise Value | 13.31B |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 111.45M |
| Shares Outstanding | 111.45M |
| Shares Change (YoY) | -6.06% |
| Shares Change (QoQ) | -1.44% |
| Owned by Insiders (%) | 1.19% |
| Owned by Institutions (%) | 97.27% |
| Float | 91.71M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 25.25 |
| Forward PE | 15.27 |
| PS Ratio | 0.71 |
| Forward PS | 0.68 |
| PB Ratio | 3.07 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.97 |
| P/OCF Ratio | 13.79 |
| PEG Ratio | 1.49 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 33.03 |
| EV / Sales | 0.98 |
| EV / EBITDA | 12.32 |
| EV / EBIT | 17.00 |
| EV / FCF | 23.39 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.32 |
| Quick Ratio | 0.55 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | 3.21 |
| Debt / FCF | 6.70 |
| Interest Coverage | 4.92 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 8.85% |
| Return on Assets (ROA) | 4.39% |
| Return on Invested Capital (ROIC) | 7.11% |
| Return on Capital Employed (ROCE) | 9.92% |
| Weighted Average Cost of Capital (WACC) | 7.27% |
| Revenue Per Employee | $544,080 |
| Profits Per Employee | $16,120 |
| Employee Count | 25,000 |
| Asset Turnover | 1.22 |
| Inventory Turnover | 4.71 |
Taxes
| Measure | Value |
|---|
| Income Tax | 132.00M |
| Effective Tax Rate | 23.66% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.84 |
| 52-Week Price Change | +37.06% |
| 50-Day Moving Average | 86.49 |
| 200-Day Moving Average | 81.10 |
| Relative Strength Index (RSI) | 54.51 |
| Average Volume (20 Days) | 1,267,796 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 9.01M |
| Short Previous Month | 8.32M |
| Short % of Shares Out | 8.08% |
| Short % of Float | 9.82% |
| Short Ratio (days to cover) | 6.93 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 13.60B |
| Gross Profit | 4.26B |
| Operating Income | 783.00M |
| Pretax Income | 558.00M |
| Net Income | 403.00M |
| EBITDA | 1.08B |
| EBIT | 783.00M |
| Earnings Per Share (EPS) | $3.43 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 157.00M |
| Total Debt | 3.81B |
| Net Cash | -3.66B |
| Net Cash Per Share | -$32.80 |
| Equity (Book Value) | 4.72B |
| Book Value Per Share | 28.21 |
| Working Capital | 1.11B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 700.00M |
| Capital Expenditures | -131.00M |
| Depreciation & Amortization | 297.00M |
| Net Borrowing | 437.00M |
| Free Cash Flow | 569.00M |
| FCF Per Share | $5.11 |
Margins
| Measure | Value |
|---|
| Gross Margin | 31.32% |
| Operating Margin | 5.76% |
| Pretax Margin | 4.10% |
| Profit Margin | 2.96% |
| EBITDA Margin | 7.94% |
| EBIT Margin | 5.76% |
| FCF Margin | 4.18% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 6.06% |
| Shareholder Yield | 6.06% |
| Earnings Yield | 3.96% |
| FCF Yield | 5.89% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $96.87 |
| Price Target Difference | 11.83% |
| Analyst Consensus | Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 4.39% |
| EPS Growth Forecast (3Y) | 9.86% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 15, 2017 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.71 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |